摘要
Introduction: Emerging evidence suggests that uremic toxins, in particular trimethylamine-Noxide(TMAO), indoxyl-sulfate(IS), and p-cresyl-sulfate(PCS), may associate with increased risk of cardiovascular events(CVe). However, whether uremic toxins increase after partial nephrectomy(PN) and their correlation with risk for CVe remains unknown. Methods: 100 patients managed with PN were retrospectively reviewed. TMAO/IS/PCS levels were examined by liquid chromatography-mass-spectrometry. Renal-parenchymal-volume-preservation(RPVP) was estimated from CT scans. Predicted risks for CVe were obtained using the Framingham score. Linear regression assessed association between uremic toxins, GFR and risk of CVe. Logistic regression evaluated factors associated with post-PN TMAO. Results: TMAO, IS and PCS increased from 1.7, 3.7 and 3.5 mmol/L before PN to 3.6, 5.4 and 7.4 mmol/L at latest follow-up, respectively, while GFR declined from 102 to 93 ml/min/1.73 m2 (all p<0.001). TMAO, IS and PCS levels all negatively correlated with GFR(all p<0.001). Predicted 10-year risk of CVe increased from 1.1% pre-PN to 1.7% post-PN(p<0.001), primarily due to increased age(p<0.001), blood pressure(p = 0.002) and total cholesterol(p = 0.003). TMAO(b = 0.038) and GFR (b = -0.02) were independent predictors for predicted 10-year CVe risk on multivariable-analysis. Increased TMAO was an early and sustained finding maintained through 5 years, unlike IS, PCS and eGFR. On multivariable analysis, increased pre-PN TMAO(OR = 2.79) and decreased RPVP(OR = 3.23) were identified as independent risk factors for higher post-PN TMAO, while ischemia type/duration failed to correlate. Conclusion: Uremic toxin levels increased after PN correlating with reduced GFR. Higher TMAO independently associated with greater predicted 10-year CVe risk. Parenchymal mass preserved rather than ischemia time or type associated with increased TMAO. (c) 2024 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
学科与关键词
- Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysisChang, Dongyuan; Xu, Xiao; Yang, Zhikai; Ma, Tiantian; Nie, Jing*; Dong, Jie*Peritoneal Dialysis International, 2022, 42(6): 622-630.被引 5
- Trimethylamine-N-Oxide Aggravates Kidney Injury via Activation of p38/MAPK Signaling and Upregulation of HuRLai, Yunshi; Tang, Haie; Zhang, Xinrong; Zhou, Zhanmei; Zhou, Miaomiao; Hu, Zheng; Zhu, Fengxin; Zhang, Lei*; Nie, Jing*Kidney and Blood Pressure Research, 2021.被引 15
- Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patientsZhang, Lei; Xie, Feifei; Tang, Haie; Zhang, Xinrong; Hu, Jianxia; Zhong, Xiaohong; Gong, Nirong; Lai, Yunshi; Zhou, Miaomiao; Tian, Jianwei; Zhou, Zhanmei; Xie, Liling; Hu, Zheng; Zhu, Fengxin; Jiang, Jianping*; Nie, Jing*Translational Research, 2022, 240: 50-63.被引 19
